Trending News
News
News
Therapeutic Effects of Tumor-Initiating Cell Probe TiY Demonstrated
A joint team of researchers from POSTECH and A*STAR prove the therapeutic effects of tumor-initiating cell probe TiY after demonstrating its staining effects.
News
New Tool Targets Cancer-Causing Gene Fusions
Oncogenic gene fusions that drive cancer progression are being targeted by a new gene editing tool from St. Jude Children's Research Hospital.
News
New Study Uses Ultrasound To Target Activation of Chemotherapy
A new study has used ultrasound to activate platinum-containing complexes that are commonly used against cancer, enhancing the accuracy of the drugs.
News
New Approach for Personalized Colorectal Cancer Treatment Developed
A team from the UNIGE has developed a new method for testing different cancer drugs, without going through the affected person’s body and without resorting to animal experiments.
News
Childhood Cancer Survivors With Healthy Lifestyles May Have Lower Mortality Risk
A new study has found that childhood cancer survivors have higher mortality than the public, but survivors with a healthy lifestyle and fewer heart disease risk factors had lower risk of mortality.
News
Link to Iron Regulation in Blood Cancer Offers Potential Treatment
A landmark discovery linking iron regulation to polycythemia vera, a rare blood cancer, has led to clinical trials of a potential new treatment for patients with the incurable disease.
News
Discovery May Keep Colorectal Cancer-Causing Bacterium in Check
Researchers have discovered that a chemically modified version of a small RNA could be used as a potential therapeutic to prevent colorectal cancer in the future.
News
“BioArm” 3D Printer Builds Mini Tumors To Test New Immunotherapies
A 3D bioprinter has been developed for cancer research – it can print mini tumors on which researchers can test potential immunotherapy treatments.
News
“Jumping Genes” May Serve as Targets for New Immunotherapies
New research suggests that transposable elements in various cancers could be used to direct novel immunotherapies to tumors that don’t typically respond to immune-based treatments.
News
New Insights Into How BRCA2 Is Linked to Cancer Risk
New research shows exactly how the gene BRCA2, linked to breast and ovarian cancer, functions to repair damaged DNA.
Advertisement